Clinical Trial Update: CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients

View source ↗

Summary

This clinical trial update examines how CYP2C19 genetic polymorphisms influence voriconazole trough concentrations in Chinese adults with invasive pulmonary asp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pulmonary Aspergillosis

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: dingshifang | Conditions: Invasive Pulmonary Aspergillosis | Status: UNKNOWN